Adjuvant chemotherapy for completely resected non-small cell lung cancer with TS-1 [S 1] - evaluation of predictive factors for prognosis
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2012
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms KOLK-2
- 27 Mar 2012 Planned End Date changed from 1 Feb 2015 to 1 Oct 2017 as reported by University Hospital Medical Information Network - Japan.
- 27 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 26 May 2008 New trial record.